It recorded a net loss of $2.0 million. Diluted earnings per share were -$0.03. Across the 4 fiscal years shown, revenue shrank from $11,862 in fiscal 2013 to $3,658 in fiscal 2016, about 32.4% a year.
USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.
| Line |
FY 2026
Mar 31, 2026
|
FY 2026
Jun 30, 2026
|
FY 2025
Jun 30, 2025
|
FY 2024
Jun 30, 2024
|
FY 2023
Jun 30, 2023
|
FY 2022
Jun 30, 2022
|
FY 2016
Jun 30, 2016
|
FY 2015
Jun 30, 2015
|
FY 2014
Jun 30, 2014
|
FY 2013
Jun 30, 2013
|
FY 2012
Jun 30, 2012
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
—
|
—
|
—
|
0
|
—
|
—
|
0
+0.0%
|
0
-38.3%
|
0
-50.0%
|
0
|
0
|
| Research and development |
0
-3.3%
|
0
+27.0%
|
0
-7.5%
|
0
-71.7%
|
0
-58.8%
|
0
-73.2%
|
0
-33.0%
|
1
+285.9%
|
0
-29.7%
|
0
+18.7%
|
0
|
| Selling, general and administrative |
1
-28.4%
|
1
-39.4%
|
2
+4.9%
|
2
-33.4%
|
3
+30.8%
|
2
+13.0%
|
2
-23.5%
|
2
+4.7%
|
2
-67.0%
|
7
+8.3%
|
6
|
| Operating income |
-1
+28.2%
|
-1
+38.7%
|
-2
-4.7%
|
-2
+34.4%
|
-3
-23.8%
|
-3
+9.8%
|
-4
+21.4%
|
-5
+2.1%
|
-5
+32.5%
|
-8
-22.0%
|
-7
|
| Income tax |
—
|
—
|
—
|
0
|
—
|
—
|
—
|
—
|
0
|
0
|
0
|
| Net income |
-2
-114.5%
|
-2
+17.7%
|
-2
-120.4%
|
12
+466.6%
|
-3
-138.5%
|
8
|
-5
+19.7%
|
-6
+2.2%
|
-6
+30.1%
|
-8
-27.9%
|
-6
|
| Basic EPS |
-0.03
+85.8%
|
-0.03
+25.0%
|
-0.04
+81.8%
|
-0.22
-214.3%
|
-0.07
|
—
|
—
|
—
|
—
|
—
|
—
|
| Diluted EPS |
-0.03
+85.8%
|
-0.03
+25.0%
|
-0.04
+81.8%
|
-0.22
-214.3%
|
-0.07
|
—
|
—
|
—
|
—
|
—
|
—
|
| Weighted average shares, basic |
57
+0.8%
|
57
+0.8%
|
57
+9.0%
|
52
+15.4%
|
45
|
—
|
23
+10.7%
|
21
+10.2%
|
19
+7.6%
|
17
+12.2%
|
15
|
| Weighted average shares, diluted |
57
+0.8%
|
57
+0.8%
|
57
+9.0%
|
52
+15.4%
|
45
+7.3%
|
42
+26.9%
|
—
|
—
|
—
|
—
|
—
|
| Other measures | |||||||||||
| Depreciation and amortization |
0
-100.0%
|
0
-100.0%
|
0
-56.1%
|
0
-3.8%
|
0
+41.7%
|
0
+40.4%
|
0
-52.9%
|
1
-36.3%
|
1
+8.1%
|
1
+5630.1%
|
0
|
| EBITDA |
-1
+28.1%
|
-1
+38.7%
|
-2
-4.7%
|
-2
+34.4%
|
-3
-23.8%
|
-3
+9.8%
|
-4
+17.2%
|
-5
-5.5%
|
-4
+37.7%
|
-7
-8.4%
|
-7
|
| Interest coverage |
-4.30x
|
-2.10x
|
-6.98x
|
—
|
—
|
-8.45x
|
-10.82x
|
-14.02x
|
-13.33x
|
-27.49x
|
-98.82x
|
| Margins | |||||||||||
| Operating margin |
—
|
—
|
—
|
—
|
—
|
—
|
-113,159.68%
|
-143,955.25%
|
-90,655.44%
|
-67,107.49%
|
—
|
| Profit margin |
—
|
—
|
—
|
—
|
—
|
—
|
-123,521.95%
|
-153,914.46%
|
-97,100.20%
|
-69,497.23%
|
—
|
| EBITDA margin |
—
|
—
|
—
|
—
|
—
|
—
|
-105,134.06%
|
-126,898.55%
|
-74,152.35%
|
-59,470.75%
|
—
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. The first column is the trailing twelve months through the latest quarter. More on our methodology.
New to this? Read How to Read an Income Statement, With a Real Example.
Company profile
- Industry
- Agricultural Chemicals (SIC 2870)
- Listed as
- BNET (OTC)
- Fiscal year ends
- June 30
- Incorporated in
- CO
- Headquarters
- Old Bethpage, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 875729
Other Agricultural Chemicals companies
- Nutrien Ltd. NTR
- CF Industries Holdings, Inc. CF
- Mosaic Co MOS
- Scotts Miracle-Gro Co SMG
- Cibus, Inc. CBUS
- American Vanguard Corp AVD
- Bioceres Crop Solutions Corp. BIOX
- Fort Technology Inc FRTT
Source: SEC EDGAR filings. This is company-reported data, not investment advice.